Protea Biosciences Group, Inc. (OTCQB:PRGB) stock surged up 50% to $0.21 cents on above average volume late in the trading day. No new news was issued since the Company reported total revenue of $2,003,286 on March 16, 2016, an increase of 13% over FY2014 revenue of $1,768,312.
Protea Biosciences provides innovative bioanalytical solutions to the pharmaceutical and life science industries by applying the Company’s proprietary technology to identify and characterize the proteins, metabolites, lipids and other biologically-active molecules which are the byproducts of all living cells and life forms. Protea is the leader in mass spectrometry imaging services (MSI), providing a revolutionary capability that enables the identification and spatial display of biologically-active molecules in tissue and cells.
Protea stock has had a 52 week range of $0.10 – $0.54.